We treated tumor cells with recombinant human RSPO4 protein and observed its effect at different time points and found that RSPO4 induced an initial increase of β-catenin level within the first hour followed by an attenuated response thereafter (Fig. S4B). Here, RSPO4 is linked to neoplasm.